马上注册登录，享用更多感控资源，助你轻松入门。
您需要 登录 才可以下载或查看，没有账号？注册
|
×
亚太区感染控制学会主席
香港玛丽医院微生物科主任
Professor Seto Wing Hong（司徒永康）
CURRICULUM VITAE （2005年版）
CURRICULUM VITAE
Name: Dr. Seto Wing Hong.
Address: 28th Floor, Blk 45, Lower Baguio Villa, 550 Victoria Rd.
Personal Particulars: Sex / Age : Male / 56
Race: Chinese
Date & Place of Birth: 16.4.48, Hong Kong.
Position:
Chief of Service & Senior Consultant (grade D4),
Dept. of Microbiology, Queen Mary Hospital,
(Teaching Hospital of University of Hong Kong)
Chairman, Infection Control, Queen Mary Hospital,
Director, Quality Improvement Unit, QMH.
Chairman, Risk Management Committee and Quality Executive Committee, Hong Kong West Cluster,
Professor(Hon), Department of Microbiology and
Clinical Trail Centre,
The University of Hong Kong.
Adjunct Professor, School of Nursing,
The Hong Kong Polytechnic University
Visiting Professor, School of Community Medicine, Health Services Management and Medical Education,
Faculty of Medicine,
University of New South Wales, Australia
Professor(Hon), Hunan Medical University,
Xiang Ya Hospital, Changsha, China.
Consultant for Ministry of Health Training Centre
Visiting Professor and Hon Consultant, Shanghai 2nd Medical University, Rui Jin Hospital, Shanghai, China
Visiting Professor, West China School of Clinical Medicine,
Sichuan, China.
Professor(Hon), in Infection Control,
Military Postgraduate Medical College,
PLA General Hospital(301), Beijing, China.
Consultant for Hospital Infection (Hon),
Chinese People's Liberation Army,
People's Republic of China.
Appointed by PLA Medical Science & Technology Committee.
Medical College: Faculty of Medicine, University of Singapore
Qualifications: (with dates)
MB,BS(1972)
MRCP(UK)(1981)
MRCPI(1981)
MRCpath(1984)
FRCPath (1997)
FFPRCPI(1992)
FHKCPath(1992) - Founding Fellow.
FHKAM (Pathology) [1994] - Founding Fellow.
American Board Certified in Healthcare Quality [CPHQ] 1996.
Other relevant training.
1.
Course in
Infection
Control
organized
by
Centers for
Disease Control, Atlanta, Georgia. (1985)
2.
Health
One
on Developing Supervisory
Skills
-
Management course
by
the
University of
Minnesota
organized
by
the Hospital Authority, March 1992.
3.
Laboratory
Management
Course
by the
College
of
American Pathologist, Boston, USA, April 1992.
4.
Course
on
Quality Assurance for Health
Professionals.
The Flinders
University
of
South
Australia
by
the
Hospital
Authority in Hong Kong,(February 1994).
5.
Course on CQI for Medical Staff Leadership and TEAM Approach. Joint Commission on Accreditation of Healthcare Organization, Chicago, USA (June 1994).
6.
Course on Patient Safety Training. National Center for Patient Safety, Department of Veterans Affairs, USA (April, 2002).
Working Experiences:
1.
House
Pediatrician
and House Surgeon, Faculty
of
Medicine, University of Singapore (1972-1973).
2.
Medical
Trainee
in
Microbiology.
University
of
Singapore (1973-1974).
3.
Full Associate, Singapore Locum Service (1975-1977).
4.
Medical Officer and Lecturer in Nursing School, Haven of Hope Hospital, Hong Kong (1978-1980).
5.
Clinical
Bacteriologist,
Hospital
Pathology
Service,
Department of Microbiology, Queen Mary Hospital,
University of Hong Kong (1980-1984).
6.
Senior
Clinical
Bacteriologist and Director,
Department
of Microbiology,
Hospital
Pathology
Service,
Queen
Mary
Hospital, University of Hong Kong (1985-1993).
7.
Infection Control
Officer, (1985-present). Chairman,
Infection
Control Committee, Queen
Mary
Hospital (1993 - present).
8.
Chief
of
Service,
Department of
Microbiology,
Queen
Mary Hospital (January 1994 - present).
9.
Director
of
Quality
Improvement Unit,
Queen
Mary Hospital (May 1994 – present), Chairman, Hospital Risk Management Committee (2001) and Quality Executive Committee (1996 – present)
Coordinator of Clinical Service (CQI/RM) – 2002.
Clinical Attachments
1.
Honorary Senior Registrar & Lecturer: St. Thomas' Hospital and Medical School (June, July 1981).
2.
Attachment,
Division of Infectious Disease, Stanford
Medical Centre, Stanford University, USA (1981).
3.
Attachment,
Department of Microbiology, the London
Hospital, Whitchapel (1984).
Awards
1.
Best Paper Award. Hospital Authority Convention, 1994
2.
Hospital Authority Research Sponsorships for CQI 1994.
3.
Outstanding Team Award of Hospital Authority (Team Leader)- 1999
4.
Outstanding Team Award of Hospital Authority (Team member)- 2000
5.
Special SARS Commendation Medal – 2003
6.
Hong Kong West Gold Badge Award for SARS – 2003
7.
Bronze Bauhinia Medal awarded by Hong Kong Government - 2004
Membership Examination Certification Board for USA.
Content Expert for International Job Analysis Committee for
Healthcare Quality Certification Board,
Examination Committee
USA – 1998 – 2001
Participation in Business Studies:
Center for Asian Business Cases (collaboration of Harvard Business School and University of Hong Kong): Continuous Quality Improvement Initiatives at Queen Mary Hospital (2000)
Membership of Editorial Boards of International Peer Review Journals.
1.
Infection Control and Hospital Epidemiology, 1996 - present.
Chief Editor: M. Decker, Office: Nashville, USA.
2.
American Journal of Infection Control, 1996 - present.
Chief Editor: E. Larson, Office: Washington DC, USA.
3.
Journal of Microbiology, Immunology and Infection (Advisory Board)
Membership of Editorial Boards of Regional Journals
1.
Quality Bulletin, 1995 - present.
Office: Hong Kong.
2.
Asian Journal of Infection Control 1996 - present.
office: Oxford, UK.
3.
Journal of Disease Management. Medimedia Asia.
Participation in World Health Organization Activities:
1. Temporary Consultant and Trainer, WHO Antimicrobial Resistance Monitoring programme.
2. Hospital Working Group member: Workshop to develop the framework document for WHO Global Strategy for the Containment of Antimicrobial Resistance.
3. National Coordinator for "Containment for Regional Certification to be Polio Free" in 2000.
4. Committee member for 1st International Consultation on Nosocomial and Health Care Associated Infections in Urology.
Professional Societies Memberships and Activities
1.
Hong Kong Medical Association (HKMA) - Member.
Member,
Subcommittee
on
Medical Waste,
HKMA
2.
President, Microbiology Society of Hong Kong (1992 - 1996).
3.
Hong Kong College of Pathology – Counsel Member (Microbiology) 1992 -1993; Chief Examiner for
Microbiology, 1993-1996.
4.
Honorary
Advisor,
Hong
Kong
Infection
Control
Nurses
Association (1989 - present).
5.
Honorary
Advisor,
Hong
Kong
Operation
Theatre
Nurses
Association (1991 - present).
6.
Honorary Consultant for Microbiology, Hong Kong Association of Medical Technologists (1990 - present).
9.
Member - American Society for Microbiology.
10.
Member,
Central
Hospital
Infection
Control
Committee,
Department of Health, Hong Kong (1987 - 1991).
11.
Member,
International
Assistance
Committee,
Society
for Healthcare
Epidemiologists
of
America
(SHEA),
1995 - 1997
12.
Examiner
in
Microbiology for
The Royal College
of
Pathologists of Australasia, 1995 to present.
13.
Board Member, Chinese Society for Microbiology, 1996 - 2001
14.
President, Asian Pacific Society of Infection Control,
1998 – present
15.
Secretary General (since 2002) and Executive Committee, Western Pacific Society for Chemotherapy, 1998 – present.
16.
President, Asia Pacific Society for Quality Healthcare, 2000
17.
Member – Expert Committee in Microbiology, Section on Laboratory Science, Chinese Medical Association (Feb. 2002 – present).
18.
Executive Committee Member, International Society of Chemotherapy (2002 to present)
International Conferences & Courses
1.
Co-chairman
for the First International Course
in
Infection Control - Peking April 1989.
2.
Committee,
ASAIHL Seminar on AIDS in Southeast Asia & the Pacific Region: Strategies for prevention & control, June 1989
3.
Chairman,
2nd
International
Conference
on
Medical Microbiology and Biotechnology towards 2000, South China, SE Asia and USA Perspective. December, Guangzhou, China, 1990.
4.
Member,
Organizing
Committee and Scientific
Committee,
7th International Congress For Infectious Diseases 1996
5.
Member, International
Hospital
Federation,
Pan
Regional Conference, Hong Kong, April 1996.
6.
Member, International Scientific Advisory Committee,
20th
International Congress for Chemotherapy, Sydney, 1997.
7.
Chairman, Ist International Congress of Asian Pacific Society of Infection Control, 1999.
8.
Chairman, 7th Western Pacific Congress of Chemotherapy and Infectious Diseases, 2000
Committees in Hospital Authority and Department of Health
1.
Member, Drug Utilization Review Committee (1992 - 2001).
2.
Member, Task Group on Management of Medical Waste (1993/94).
3.
Member, Working Group for Chemical Waste Disposal (1994).
4.
Member, HA Coordinating Committee for Pathology.
5.
Member, Programme Committee, HA Convention 1994.
6.
Member, Subcommittee for Clinical Indicators for Microbiology, 1994.
7.
Member, Hospital Infection Control Task Force, (1995-present)
8.
Member, Working Group on AIDS Management in
HA
Hospitals 1994.
9.
Commissioning
Committee
for Northern District
Hospital
and Tseung Kwan Ho Hospital. 1995/96.
10.
Expert Group on Avian Flu, Department of Health (1997 – present)
Invited as Speaker for International & Overseas conferences:
1.
Local
Interferon Treatment of Intraepithelial
Neoplasia
of the
Cervix.
National Symposium on
Interferon,
Kwangtung, China 1984.
2.
Communication
in
Infection Control.
Symposium
for
Opinion Leaders
in
Microbiology
organized
by
Eli
Lilly. Indianapolis, USA, April 1986.
3.
Antimicrobial
Resistance
of Haemophilus influenzae
and
the epidemiology of ampicillin-resistance strains in Hong
Kong. Symposium
on
Haemophilus
influenzae
by
the
Infectious Diseases Society of Taiwan. Taipei, Oct. 1987.
4.
Infection Control.
Medical Superintendents Development program for
Key
Hospitals and Health
Bureaus
of
China.
Ministry of Public Health, Kwangtung, China. March 1988.
5.
Management
of
Infection in the Immunocompromised
Host.
2nd Cancer
Congress,
Philippine Society of
Medical
Oncology. Manila Dec. 1988.
6.
The
Development of Infection Control Programs in
Hong
Kong. The
Inauguration
Symposium
of
the
National
Nosocomial
Society of China Sept. Szechuan 1989.
7.
Plenary
speaker
for
Nurses
Association
of
Macau;
Annual
General Meeting and Seminar, Macau. 1990-1993
Topics: 1990: Overview of Infection Control.
1991: Patient care practices in Infection Control.
1992: New developments in Infection Control.
1993: Hospital Waste Management.
8.
In-service
Education in Infection Control. Infection
Control Symposium organized by the Dept. of Medicine, The University of Western Australia, Fremantle. May 1990.
9.
Gastrointestinal
Infections
:
Management
of
Bacterial
Diarrheas.
International
Symposium
on
the
use
of
Fluroquinolones. Bermuda 16-19 August, 1990.
10.
The
Implementation
and Assessment of an
Infection
Control Education
Programme.
2nd International Conference
of
the Hospital Infection Society. London, Sept. 1990.
11.
Implementing
Infection
Control
Policies
:
Australian
Infection
Control
Association, 4th
National
Conference. Perth, Western Australia. 2nd to 5th October, 1990.
12.
The
Use
of Surgeon-specific Wound Infection Rates
in
Hong Kong. The 2nd National Conference of the Nosocomial
Society of China. Yunnan, China, October 1990.
13.
Special symposium: Lomefloxacin: Western Pacific
Experience. 2nd
Western
Pacific Congress on
Infectious
Diseases
and Chemotherapy. Pattaya, Thailand, 11-14th December, 1990.
14.
The
Use
of
Participatory
Decision
Making
in
the
Implementation
of Infection Control Policies. 6th
National Congress
of
the
Australasian
Infection
Control
Nurses Association. Brisbane, October 1992
15.
Use
of Lomefloxacin for the treatment
of
gastro-intestinal infections.
Special
Symposium in
the
3rd
Asian-Pacific Conference for Chemotherapy, Bali, Indonesia, December 1992
16.
New Strategies on Infection Control in Hospitals. 13th Annual Scientific
Meeting,
Academy
of
Medicine
of
Singapore,
Singapore,
Chapter of Physicians. 16-17th January 1993.
17.
A Survey
of
Medical Waste Disposal in Hong
Kong,
and
the Formulation
of
a Code of Practice. 18th
Congress
of
the Confederation
of
Medical Association in
Asia
&
Oceania. Malacca, 18-21 August 1993.
18.
A New
Classification
for Orthopedic Wound
Infections.
The
3rd National Conference of the Nosocomial Society of
China.
Fukien, 25-27th October 1993.
19.
Special
Plenary
Speaker
for The
Infection
Control
Week, Singapore General Hospital (18-21st of January 1994).
Topics: "Protecting the Health Care Worker."
"The Myth of Medical Waste"
"Nosocomial Infections: changes and challenges".
20.
Infection
Control
and
Dentistry.
Seminar
for
Continuing Education. Singapore Dental Association, 19th January 1994.
21.
Invited Plenary Speaker on:
The Role of the Microbiology Laboratory in Infection Control.
Medical Waste and Environmental Pollution.
World Congress of Medical Technology, Hong Kong, July 1994.
22.
Invited as Plenary Speaker on 2 topics: Staff compliance with Infection
Control policies and Training the workforce.
3rd International Conference of the Hospital Infection
Society, London, September 1994.
23.
Invited
Speaker
for
Tan
Tock
Seng
150th
Anniversary Celebration
Seminar:
Implementation of
Infection
Control Guidelines
through
the Understanding
of
Human
Behavior,
Singapore, October 1994.
24.
First
Asian-Pacific
International
Conference
on
Hospital Infection. A Survey
of Medical Waste Disposal in Hong
Kong Hospitals,
and
the
Impact
of the
Code
of
Practice on
Improving practices. Beijing, Oct. 25-27, 1994.
25.
4th
Western
Pacific Congress of Chemotherapy
&
Infectious Disease.
Cost benefit
treatment
protocols
developed
by multi-variate
analysis
of
risk
factors
associated with antibiotic resistance, Manila, Dec.1994.
26.
6th Congress of Indonesia Society for Clinical
Microbiology, 1995. Jarkarta Two Topics: Haemophilus Influenzae
Pneumonia and MRSA Infections.
27.
Workshop
for Infection Control, organized by the
Department of Health, Republic of Vietnam, Hanoi, 1995.
28.
6th
Annual Scientific Meeting by the Society
of
Healthcare Epidemiologists
of
America (SHEA),
Washington
DC,
April 1996.
Meet
the Consultants - Getting
Started
in
Quality
Management.
29.
International
Hospital Federation, Pan Regional
Conference, Hong Kong, April 1996.
Speaker in two seminars: CQI and Medical Audit.
Implementing the CQI and Infection Control Linkage.
30.
1st
Inaugural National Conference, The National PLA
Society for
Infection
Control, May, 1996. Beijing. What's New
in
Surgical Wound Infection Control.
31.
7th.
International Conference in Infectious
Diseases,
Hong Kong, June, 1996. Speaker in three Seminars:
Maximizing the Infection Control and CQI Linkage
Synergy;
Cost Benefit Antibiotics Treatment Protocol;
Antibiotics
Resistance Monitoring in Asia.
(World Health Organizatin Seminar).
32.
The
lst National Anti-infection Meeting June 15-17,
1996
- Beijing,
China
by the Chinese
Medical
Association.
The Implementation of Universal Precautions in Asian Hospitals.
33.
4th
International Conference on Infection
Control.
Dublin, Ireland.
Sept.
1996.
Maximising
the
Infection
Control
and
CQI
linkage.
34.
5th
Western Pacific Congress on Chemotherapy and
Infectious Diseases.
Singapore, December 1996.
Preventing
Nosocomial Airborne Infections and TB Transmission.
35.
4th
National Conference of the Nosocomial Society of
China. Sian,
15th - 17th. October 1996. The Infection Control
and Continuous Quality Improvement Synergy in the Hospital.
36.
International
Conference
on
Improving
Use
of
Medicines. Chiangmai,
Thailand,
April
1997.
The
Implementation
of Immediate Concurrent Feedback for Control of Antibiotics.
37.
20th
International
Congress of Chemotherapy.
Sydney, Australia.
July 1997: Initiating Nation-wide Infection Control Programmes in Developing Countries.
38.
International College of Surgeons and New Changi Hospital: Combined Scientific
Meeting.
Singapore, July 1997.
(1) Approach to Surgical Wound Infection Surveillance.(2) Meeting
the Quality Assurance
Challenge
in
Infection Control.
39.
Asian Healthcare Convention of Asian Hospital Federation, 3-6 August
1997,
Kuala Lumpur, Malaysia. The paradigm shift
needed
for Continuous Quality Improvement.
40.
International Conference on Emerging Pathogens. 8 - 11, March 1998, Atlanta, USA. Measures for H5N1 Outbreak Control in Hong Kong's Public Hospitals. WH Seto & WM Ko.
41.
2nd European Congress of Chemotherapy, 10 - 13 May, 1998, Hamburg, Germany. Modifying antibiotics prescribing behaviour.
42.
23rd World Congress of Medical Technology, 28 June – 3rd July, 1998. Singapore.
(1)
Emerging antibiotics resistance (2) CQI in the Laboratory.
43.
Special Invited Lecture at the Medical Faculty, University of Tennessee, Memphis, August 1998.
The H5N1 Outbreak in Hong Kong: issues of clinical management and infection control
44.
4th International Conference of the Hospital Infection
Society, Edinburgh, September 1998. Opinion Leaders and Studies on Patient Care Activities Requiring Handwashing.
45.
International Symposium on Infectious Diseases by Infectious Diseases Society of China, November,1998. Prevention & Control of Nosocomial Infection.
46.
6th
Western Pacific Congress on Chemotherapy and
Infectious Diseases.
Kuala Lumpur, December 1999. The Epidemiology of Nosocomial Infections.
47.
Annual Meeting of the Nosocomial Infection Control Society of Taiwan. Taipei January 1999. Effective use of Surveillance and Policy Implementation for Control of Hospital Infection.
48.
5th Annual Convention of the Philippines Infection Control Society, Manila, May 1999. The Control of Tuberculosis in Hospital for Developing Countries.
49.
Ist International Congress of the Asia Pacific Society of Infection Control. Hong Kong, August 1999 i) Infection Control Measures in TB - How far should we go? ii) Territory-wide Infection Control Networking.
50.
8th ASEAN Conference in Medical Laboratory Technology, BSB, Brunei, September 1999. Quality Improvement in the Microbiology Set-up.
51.
3rd National Conference on Clinical Pharmacology of Antimicrobial Agents. Beijing, Nov. 1999.
Using Guidelines to Improve Antibiotics and Drug Usage
52.
4th Dicennial International Conference on Nosocomial Infections. Atlanta, March 2000. Preventing tuberculosis in the International Setting.
53.
9th International Conference of Infectious Diseases. Buenos Aires, April, 2000. From Infection Control to Antibiotics Control.
54.
National Meeting of The Indonesian Association of Health Laboratory Technologists, 26-28th April, 2000, Jakarta, Indonesia. Total Quality Management (plenary session). Evaluation of Medical Technologist Performance (symposia).
55.
Australian Infection Control Association First Biennial Conference, 3-5 May 2000
Adelaide, South Australia, May 2000. Infection Control as a Quality Management Issue.
56.
7th Asean Pediatrics Federation Conference, 2-4th June, Kuala Lumpur, Malaysia. Surveillance for Nosocomial Infection in the General Pediatric Wards.
57.
27th Annual Educational Conference and International Meeting, Association for Professionals in Infection Control and Epidemiology, Minneapolis, June 2000. Avian Flu in Hong Kong.
58.
40th ICAAC - Global Resistance Day by American Microbiology Society, 16th September, 2000. Toronto, Canada. The Hong Kong Experience.
59.
International Congress of Medicine in the Tropics. 4th November 2000, Kuala Lumpur. Public Health and Infection Control of Bird Flu – the Hong Kong Experience.
60. 7th Western Pacific Congress on Chemotherapy and Infectious Diseases. December 2000. Hong Kong. Keynote Lecture: Making Infection Control Works – managing the human factor.
61. Beijing International Symposium on Antibiotics. December 2000, Beijing. Networking for Territory-wide Surveillance and Control of Infectious Diseases
62. 1st Indonesian Symposium on Infection Control. Feb. 2001. Making Infection Control Really Works – managing the human factor.
63. 3rd International Symposium on Antimicrobial Agents and Resistance. April 2001, Plenary Session: MRSA in the Community – impact on Nosocomial Infection Control.
64. New Zealand Infection Control Conference. August 2001. Plenary Speaker Wellington: Emerging Infections.
65. UK National Infection Control Conference 2001. Blackpool, September 2001. Keynote speaker: Protecting the Patient.
66.International Congress on Infectious Diseases. March 2002, Singapore:
Relative Contributions of Technology and behavior Changes for Infection Control Outcomes
67.Plenary Speaker: “Handwashing – Is Compliance Possible?” June Brisbane, Australian Infection Control Association.
68.Plenary Speaker: Infection Control: Towards Successful Approaches. November, 2002 1st Asian Congress of Pediatric Infectious Diseases.Patayya, Thailand
69.8th Western Pacific Conference on Chemotherapy and Infectious Diseases December 2002. Speaker: Outbreak Investigation:
70. 4th International Symposium on Antimicrobial Agents and Resistance. July 2003, Preventing antimicrobial resistance by infection control practices. Seoul, Korea.
71. 3rd Asia Pacific Forum on Quality Improvement in Health Care, September 2003: Staff training for CQI in Healthcare: implementing effective programmes in Asia. Auckland
72: Conjoint conference by China Medical Association and Hong Kong Medical Association on SARS. September 2003, Plenary session: Infection Control in SARS.
72. International Society for Chemotherapy congress on Community Acquired Pneumonia. September 2003, Plenary: “Infection Control for SARS in the hospital – what really works”. Ontario, Canada.
73. 2nd Asia Pacific Congress in Infection Control: Plenary Session on Outbreak Investigation. March 2004, Singapore
74. International Congress in Infectious Diseases: Fluroquinolone resistance and Clinical Management of SARS. March 2004. Cancun, Mecixo.
75. International Society for Chemotherapy congress on Fever in the Neutropenic. Plenary Session on Infection Control – what is the minimum? June 2004, Kuala Lumpur.
76. International Federation in Infection Control Conference: Control
of SARS in the hospital Setting – experiences from Hong Kong.
October 2004, Proec, Croatia.
77. 44th Annual ICAAC, November 2004 Symposium on SARS, Washington DC, USA.
78. 12th Asean Pediatric Federation Conference. Plenary Lecture: Infection Control for SARS patients with special reference to the pediatric population. November 2004, Pattaya, Thailand.
78. 9th WPCCID, Plenary Lecture: Patients Isolation – its implication for resource-limited country, December 2004, Bangkok.
Teaching Experience:
1.
Full
participation
in
teaching
Microbiology
for
medical
students in the Faculty of Medicine, University of Hong Kong (1980-present)
2.
Course director and Faculty for Infection Training Course
for infection
control nurses and infection control officers
in Hong Kong (1986-present).
3.
Invited
Faculty
for
Infection
Control
Training
Course,
Western Australia, Fremantle, 1990
4.
Director
and
Faculty for Infection
Control
Course
jointly organized
by
Department
of Public Health,
PRC,
and
the
Faculty of Medicine, HKU - 1992 and 1993.
5.
Faculty
member
of
Certificate
Course
of
the
Hong
Kong
Association of The Pharmaceutical Industry, 1990 - present.
6.
Director and Faculty for on Healthcare Quality jointly organized by APSHCQ and PKKI, Business Center, University of Hong Kong.
7.
Director for Annual Course on Hospital Epidemiology for Society for Healthcare Epidemiologists of America in Hong Kong, 1995 to 1996.
Teaching Experience in Antimicrobial Testing
1.
3-day seminar on antimicrobial testing, Dept. of
Microbiology, Japanese Friendship Hospital, Beijing, 1994
2.
3-day
Course on Antimicrobial Testing, at the
University
of Indonesia, Dept. of Microbiology, with Dr. Sudarmono - March 1995.
3.
3-day workshop on antimicrobial testing organised by Dept.
of Microbiology,
Choy Ray Hospital, Ho Chi Min City,
Vietnam, Sept. 1995.
4.
Invited
Faculty for Workshop for Antimicrobial
Sensititivity Testing,
Malaysian Society for Microbiology, Kuala
Lumpur, March, 1996.
Other Activities
1. Director, Haven of Hope Hospital (1987 - 1997)
2. Part-time Singapore Special Police Constabulary, 1975-1977.
3. Best Shooting Award. Singapore Special Police Constabulary. 1975.
Full Publications
1.
Tan
RJS.
Seto
WH,
Sng EH,
Tay
L.
Wee
R:
Antimicrobial
Sensitivity Testing of Hospital Isolates Suing a Standardized Disc Method. Asian J of Modern Medicine. 1974;10;362-363.
2.
Tan RJS, Seto WH, Sng EH: Prevalence of Leptospiral Serogroups in Singapore. Ann Academy of Medicine. 1975;4:177-179.
3.
Seto
WH:
Comparative Analysis of Hospital Services
for
the Management
of Infectious Diseases. Singapore Medical
Journal. 1983;24:221-223.
4.
Seto
WH,
Choo YC, Hsu C, Merigan TC, Tan YH, Ma HK,
Ng
MH: Local
Treatment of Intraepithelial Neoplasia of Cervix
with IFN-alpha
and
IFN-beta. In The Biology
of
the
Interferon System.
Maeyer ED, Schellekens H -
eds.
Amsterdam:Elsevier Science Publishers. 1983: 505-510.
5.
Choo YC, Seto WH, Hsu C, Merigan TC, Ng MH, Ma HK:
Antitumour Activity
of Interferons on Intraepithelial Neoplasia of
the Cervix. Proceedings of 13th
International
Congress of Chemotherapy.1983 :266-270.
6.
Huang
CY,
Chan
FL,
Seto
WH:
Moya
Moya
Disease,
A
Clinical,
Radiological and Microbiological Study.
Neurology 1983;33:165.
7.
Seto
WH, Lau JTK: Septicaemia due to Yersinia
Enterocolitica Biotype 1 in Hong Kong. J of Infect 1984;8:28-33.
8.
Seto
WH:
Anaerobic Infections in South
East
Asia.
Medical Progress 1984;2:10-12.
9.
Hsu
C, Choo YC, Seto WH, Pang SW,Tan YH, Merigan TC,
Ng
MH: Exfoliative
Cytology
in
the
Evaluation
of
Interferon
Treatment
of Cervical Intraepithelial Neoplasia. Acta
Cytol 1984;28:111-117.
10.
Choo YC, Seto WH, Ma HK: Cervical-vaginal bacterial flora and fever
morbidity
during
radium implant. Aust
NZ
J
Obstet Gynaecol 1984;34-38.
11.
Tsang
RSW,
Seto WH, Leung YK, Chow K, Li KS:
A
pathogenic mycobacterium
isolated
on
simple
agar
media.
Laboratory Medicine 1985;6:374-376.
12.
Lee YK, Seto WH, Fang D: Mycobacterium chelonei infection
of the back and extremities: Report of an Iatrogenic Epidemic. J of HKMA 1985;37:89-91.
13.
Choo YC, Hsu C, Seto WH, Miller DG, Merigan TC, Ng MH, Ma HK: Intravaginal Application of Leucocyte Interferon Gel in
the treatment
of
Cervical
Intraepithelial
Neoplasia.
Arch Gynecol 1985;237:51-54.
14.
Seto
WH:
The changing bacteriology
of
recurrent
pyogenic cholangitis in Hong Kong. J of Trop Med & Hyg.
1985;88:359-365.
15.
Choo
YC, Hsu C, Seto WH. Merigan TC, Ma HK, Ng MH:
Cervical Intraepithelial Neoplasia treated by perilesional
Injection of Interferon. Br. J O & G 1986;93:372-379.
16.
Yuen
WC,
Chan
YF,
Seto WH,
Poon
GP,
Wong
KK:
Chronic Lymphadenopathy
caused
by
Penicillium
Marneffei
- a
condition mimicking Tuberculosis Lymphadenopathy. British
J of Surgery 1986;73:1007-8.
17.
Seto WH, Ong SG, Ching TY, Lui SH, Yau TO: Educational
Needs in
Patient
Care Practices in Hong Kong. Am.
J
of
Infect Control 1988;16:19-25.
18.
Seto
WH,
Pang SW, Yung WH, Tam ACY,
Luk
WK:
Longitudinal analysis of antimicrobial resistance of H. influenzae and an epidemiological
study
of ampicillin resistant
strains
in Hong Kong. JAMA SEA 1988;4:24-28 (supplement).
19.
WH Seto, TY Ching, KY Yuen, YB Chu: The epidemiology of blood and body fluid spillage in a teaching hospital. Chinese J of Nosocomiology: 1991:1:6-10
20.
TY Ching, WH
Seto:
Hospital
Utilization
of
Chlorine Disinfectant
in
Hong
Kong
- A
need
for
education
and surveillance. Proceedings
of
the
2nd
International Conference on Infection Control.1988:155-164.
21.
WH
Seto,
TY
Ching,
SH Ng,
SG
Ong:
The
Application
of Influencing Tactics in Infection Control : A study in
staff compliance. Proceedings of the 2nd International
Conference on Infection Control 1988: 155-164.
22.
Seto
WH,
Chu
YB,
Pang
SW, Luk
WK,
Tam
AYC,
Yung
WH: Susceptibility of Haemophilus influenzae in Hong Kong.
JAMA SEA 1989;5:1 (supplement).
23.
A case report of Anaerobiospirillium
succiniproducens
septicaemia. J of Infectious Disease. 1989;159:153-154.
24.
TY
Ching, WH Seto: Hospital Usage of Chlorine
Disinfectants in
a Hepatitis B Endemic Area - A prevalence survey in 20 hospitals. J Hospital Infection. 1989;14:39-48.
25.
WH
Seto,
TY
Ching,
JPM Fung,
R
Fielding:
The
Role
of
Communication in the Alteration of Patient Care Practices. J of Hospital Infection. 1989;14:29-38.
26.
Yuen
KY,
Seto WH, Ong SG: The significance
of
Branhamella catarrhalis
in bronchopulmonary infection - a
case-control study. J of Infect 1989;19:251-256.
27.
Seto WH: The proper collection of microbiological
specimens. In Handbook for Trainees in Infection Control. Chen MK, Wang A eds. Peking:Peking Union Medical College 1989:179-180.
28.
WH
Seto
:
Editorial: The progress
of
Hospital
Infection
Control in Hong Kong. J of HKMA. 1990;41:222-223.
29.
WH
Seto,
TY
Ching:
A survey
on
the
usage
of
chlorine
disinfectants in Hong Kong. J of HKMA. 1990;41:233-236.
30.
WH Yung, WH Seto: The Training of Infection Control Nurses in Hong Kong. J of HKMA.1990;41:237-238.
31.
WH
Seto,TY Ching,YB Chu, Ng SH, Ong SG: Evaluation of
staff compliance with influencing tactics in relation to infection control
policy
implementation.
J
of
Hospital
Infection 1990;15:157-166.
32.
WH
Seto:
The
Development
of
Hospital
Infection
Control Programmes in Hong Kong. Proceeding for the National Course on Nosocomial Infection Control in China.1990:95-101.
33.
WH
Seto,
TY
Ching,
SH
Ng
et
al:
The
utilization
of
influencing
tactics
for the
implementation
of
infection
control
policies.
J
of
Infection
Control
and
Hospital
Epidemiology 1990:3: 144-150.
34.
WH
Seto,
TY
Ching, YB Chu, R Fielding:
Reduction
in
the frequency
of
needle recapping by effective education
-
a need for conceptual alteration. J of Hospital Infection
and
Hospital Epidemiology. 1990; 11:175-177.
35.
WH
Seto,
TY
Ching, SG Ong:A
scheme
to
review
infection
control guidelines for the purpose of implementation in
the Hospital. J of Hospital Infection and Hospital
Epidemiology 1990; 11:255-257.
36.
WH
Seto:
The
Application of
the
behavioral
sciences
in
infection control in The Textbook of Nosocomiology. Wang SQ, BL Chuang - ed. 1990:648-654: Science and technology
press, China.
37.
TY
Ching,
WH Seto: The efficacy of
the
infection
control liaison nurse. The Journal of Advanced Nursing.1990;15:1128-1131.
38.
Yip
AWC, Yuen KY, Seto WH, Choi TK: A
new
semiquantitative culture
method
for
early
detection
of
surgical
wound
incisional
wound
infection.
J
of
Infectious
Disease 1990;161:972-976.
39.
Yuen
KY,
Seto WH, Choi CH, Ng WS, Ho SW, Chau
PY:
Strept. zooepdemicus (lancefield group C) septicaemias in Hong Kong. J of infection 1990:21:241-250.
40.
Yuen
KY,
Seto
WH,
Tsai KH,
Hui
WT:
Cysteine
dependent
Escherichia
coli septicaemia. J of
Clinical
Microbiology. 1990;28:1047-1048.
41.
Yuen KY, Seto WH, Hui WT, Chau PY: Mutiresistant
pnemococcus in Hong Kong. J of Antimicrobial Chemotherapy.
1990;24:721-723.
42.
TY
Ching, Seto WH: Hospital Usage of Chlorine
Disinfectants in
a Hepatitis B Endemic Area - a prevalence survey
in
20 Hospitals. (Selected for reprint in the Hepatology Digest)
43.
Yeung CK, Yuen KY, Fu KH, Tsang TM, Seto WH, Saing H: A rapid endoscopy room diagnosis
of Campylobacter Pylori
infection in
children.
J
Pediatric
Gastroenterology
&
Nutrition. 1990:10:357-360.
44.
Pritchett
CJ, Seto WH: The surgeon-specific wound
infection rate - a worthwhile strategy for Asian hospitals. Asian J of Surgery 1990:13:121-124.
45.
Seto WH, Yuen KY, Yip AWC: An open randomized trail comparing the
efficacy
of oral lomefloxacin
and
cefaclor
for
the treatment
of surgical wound infections. Proceedings of
7th Mediterranean
Congress
of
Chemotherapy. Journal of Chemotherapy. R Gomez-Lus & G Cocuzza (editors).
pp437-438, 1990.
46.
Seto WH: AIDS in ASAIHL countries - A summary of the
country papers. Proceeding of the ASAIHL Seminar on AIDS (in-press)
47.
Yuen
KY,
Seto
WH, Li KS, Leung
R:
Trichosporon
beigelii peritonitis
in continuous ambulatory
peritoneal
dialysis. Journal of Infection. 1990; 20:178-180.
48.
WH Seto, TY Ching, JPM Fung, WL Seto: The employment of
ward opinion
leaders
for
continuing
education
in
the
hospital. Medical Teacher, 1990. 12:209-217.
49.
WH
Seto, YB Chu: Who are Collecting the Microbiology
Specimens?. Bulletin of HKU Medical Laboratory Science
Graduates Association, 1990:7-10.
50.
WH Seto, Yuen KY: Semiquantitative culture of sputum for
the diagnosis
of
nosocomial pneumonia in
intubated
patients. Chinese J of Epidemiol.1991:12:supplement 5:13-15.
51.
WH
Seto,
TY Ching, YB Chu, WL Seto: Social
Power
and
the compliance of nurses and House keeping staff with
Infection Control policies. Am. J of Infection Control 1991:2:42-44.
52.
WH
Seto,
TY Ching, KY Yuen, YB Chu:
Analytical
survey
of blood and body fluid exposures in a large teaching hospital. Chinese Journal of Nosocomiology. 1991 (1):6-10.
53.
WH
Seto,
TY
Ching,
Yuen KY et al
:
The
enhancement
of
infection
control
in-service
education
by
ward
opinion leaders. Am. J of Infection Control 1991:19:86-91.
54.
Seto
WH,
Ching
TY,
Yuen KY,
Lam
WK:
An
evaluation
of
disposable
O2
humidifiers during and in between
usage
on patients.
Infection
Control
and
Hospital
Epidemiology 1991:11:604-605.
55.
Yung
WH, Seto WH, Pritchett CJ: Surgical wound
surveillance by
routine
wound
swabs
and
Kardex
review.
Journal of Infection 1991(23):161-167.
56.
Seto
WH,
Yuen KY: The successful treatment
of
Branhamella catarrhalis
bronchopulmonary
infections
in
adults
with
amoxycillin.
Journal
of
Antimicrobial
Chemotherapy 1991;27:(1) 146-147.
57.
WH Seto, MK Chen, TY Ching: Concise Handbook on Microbiology. Department of Public Health, PRC. 1991.
58.
KH
Chan,
KS
Mann,
WH
Seto:
Infection
of
a
shunt
by
Mycobacterim
fortuitum
: Case
report.
Neurosurgery
1991 29;3:472-474.
59.
WH
Seto:
Antimicrobial susceptibility patterns
in
general practice. Focus on Community Infection.1991(1)4:1-2.
60.
KY
Yuen,
WH Seto, TY Ching, WC Cheung, Y
Kwok,
YB
Chu:An Outbreak
of Candida tropicalis peritonitis in
intermittent peritoneal
dialysis patients. 1992 J of Hospital
Infection 22:1:65-70
61.
WH
Seto, TY Ching, KY Yuen, YB Chu, Ong SG:
Estimating
the extent
of practice for CDC infection control guidelines
in Hong
Kong
hospitals.
Chinese J
of
Epidemiol.
1992
12:
supplement 5:6-12.
62.
WH
Seto, FL Lau, EH Gotuzzo, C Carillo: Lomefloxacin
versus Trimethorprim /
Sulfamethoxazole in the
Treatment of Adults with
Acute
Bacterial
Diarrhea. International
Journal of Antimicrobial Agents 1992 (2);61-66.
63.
Yuen
KY,
WH
Seto, PY Chau:
An
evaluation
of
in-patient
consultation
by
clinical
microbiologists
in
a
teaching hospital. J of Infection 1992: July Vol. 25,(1):29 - 37
64.
WH
Seto:
The
use
of
Antibiotics
in
the
Treatment
of Respiratory Tract Infection (Editorial). JAMA Southeast Asia 1993:(9)5:7,8.
65.
WH
Seto: The Implementation of Infection Control
Guidelines Through
the
Understanding of Human Behaviour.
Journal
of Academy of Medicine, Singapore (Accepted and in press).
66.
WH
Seto, CK Chow, MT Ng, CC Lam, LH Sinn, WL Yu, SW
Wu,
KM Wong:
Cefaclor in the Treatment of Upper Respiratory
Tract Infections
in Children. JAMA Southeast
Asia,
1995;2:18-22 (supp).
67.
WH Seto: Treatment of Medical Waste in Hong Kong.
Proceedings of the CMAAO Symposium (30th CMAAO Midterm Council
Meeting) 1995, 152-155.
68.
Seto WH Training the Work Force - models for effective education
in infection control. Journal of
Hospital
Infection, 1995. 30 (supp.) 241-247.
69.
Seto
WH. Staff Compliance with Infection Control
Practices: application of the behavioural sciences. Journal of Hospital Infection, 1995: 30 (supp.) 107-115.
70.
Seto WH. Understanding CQI climate in Hong Kong Hospitals for Strategic
Quality
Planning. Proceedings
of
the
Hospital Authority Convention, 1995: 171-174.
71.
WH
Seto: The Treatment of
Ampicillin-resistant
Haemophilus influunezae. Medicine Digest. 1995:13(7).
72.
WH Seto, TY Ching, MHV Kou, SC Chiang, IJ Lauder, CR
Kumana:
Hospital
Antibiotic
Prescribing Successfully
Modifiec
by "Immediate Concurrent Feedback". British J of
Pharmacology; 1996:41:229-234.
73.
Seto WH: Understanding the "Shift" in the CQI paradigm shift. Editorial, Quality Bulletin.1(1): 1-3, 1996.
74.
WH
Seto:
Infection
Control Policies -
learning
from
the
behavioural
sciences. Asian Journal of
Infection
Control, 1:2-4, 1996.
75.
TY Ching, WH Seto: Antibioitcs Prophylaxis for Prevention
of Surgical Wound Infections Successfully Modified by Immediate Concurrent Feedback. Chinese Journal of Epidemiology,
1996; (17) 4-B: 184-185.
76.
WH
Seto,
TY
Ching: The Infection
Control
and
Continuous Quality Improvement Synergy in the Hospital. Chinese Journal of Epidemiology, 1996;(17) 4-B: 186-187.
77.
WH
Seto.
CQI
and
Clinical
Audit.
Proceedings
of
the
International
Hospital Federation Pan Regional
Conference, 1996:17-18.
78.
WH
Seto. Implementing the Infection Control and CQI
Linkage in
the Hospital. Proceedings of the International
Hospital Federation Pan Regional Conference, 1996:141-144.
79.
R. Lee, WH Seto: Editorial: CQI, its time for an Asian Focus, JAMA, sea.
1997:13:1:11-12.
80.
Ho P. L., Seto
W. H. : Guest
Editorial:
The
Role
of Fluoroquinolones. Medical Progress 1997:2:5-7.
81.
Woo
PCY, Chiu SS, Seto WH, Peiris M: Cost
Effectiveness
of Rapid
Diagnosis
of Viral Respiratory Tract
Infections
in Pediatric
patients. Journal
of
Clinical
Microbiology 35:6:1579- 81, 1997
82.
Yuen
KY,
Yam
WC,
Wong LP,
Seto
WH:
Comparison
of
Two
Automated
DNA Amplification Systems with a Manual
One-tube Nested
PCR Assay for Diagnosis of
Pulmonary
Tuberculosis. Journal
of Clinical
Microbiology, (35)6:1385-1389, 1997
83.
WH Seto, PTY Ching, CR Kumana: Rubber emboli, Eur. Journal of Pharmacology, 53:5:313-315, 1998.
84.
Chan KC, Luo RX, Chen HL, Ng MH, Seto WH, Peiris JSM: Development and Evaluation of an Epstein-Barr Virus Immunoglobin M Enzyme-linked Immunosorbent Assay Based on the 18-Kilodalton Matrix Protein for Diagnosis of Primary EBV Infection. Journal of Clinical Microbiology,(36)11,1998
85.
Ho PL, Luk WK, Wong SY, Seto WH, Lo YJ, Yuen KY: Pseudobacteremia with Amoxycillin-clavulanic acid - resistant E coli traced to cross contamination during blood culturing. Chinese Medical Journal, (111) 6: 570-576, 1998
86.
Seto WH: Hospital Infection Control - current developments and the need for a worldwide network, Medical Progress, 1998;25 (12): 22-24
87.
C Kumana, Ching TY, E Cheung, Y Kong, M Kou, C Chan, K Chu, WH Seto, S Lam: Antiulcer drug prescribing in hospital successfully influenced by “immediate concurrent feedback” Clinical Pharmacology & Therapeutics 1998 (64)5:569-574
88.
Yam
WC, Yuen KY, Seto WH: Direct Detection of Mycobacterium tuberculosis in Respiratory specimens using an automated DNA amplification assay and a single tube nested PCR. Clin Chem Lab Med 1998(36)8:597-599
89.
WC Yam, DNC Tsang, TL Que, M Perris, WH Seto, KY Yuen: A Unique Strain of Escherichia coli 0157:H7 That Produces Low Verocytotoxin Not Detected by Use of a Commercial Enzyme Immunoassay Kit. Clinical Infectious Diseases 1998;27:905-6
90.
MH Ng, HL Chen, RX Luo, P Woo, J Sham, J Huang, WH Seto, P Smith, B Griffin: Serological diagnosis of nasopharyngeal carcinoma by enzyme linked immunosorbant assay: optimization, standardization and diagnostic criteria. Chinese Medical Journal 1998: 111 (6): 531-536
91.
PL Ho, TL Que, DNC Tsang, TK Ng, KH Chow, WH Seto: Emergence of Fluoroquinolone Resistance among Multiply Resistant Strains of Streptococcus pneumoniae in Hong Kong. Antimicrobial Agents and Chemotherapy, 1999(43)5:1310-1313
92.
CB Bridges, JM Katz, WH Seto et al: Risk of Influenza A(H5N1) Infection Among Healthcare Workers Exposed to Patients with Influenza A(H5N1)
J Infectious Diseases, 2000;181:344-8
93.
Neuraminidase Inhibitor Flu Treatment Investigator Group (WH Seto, member): Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. The Lancet 2000;355: 1845-50
94.
Seto WH, Ling ML, Ngeow WF: Identification of Risk Factors Associated with Antimicrobial Resistance: Epidemiologic Approach. (Accepted for International Journal of
Infectious Diseases).
95.
Seto WH: Preventing Mycobacterium tuberculosis Transmission in International Health-Care Settings. Emerging Infectious Diseases
2001, Vol.7, No. 2 Mar–Apr
96.
PL Ho, WC Yam, TL Que, DNC Tsang, WH Seto, TK Ng, WS Ng. Target site modifications and efflux phenotype in clinical isolates of Streptococcus pneumoniae from Hong Kong with reduced susceptibility to fluoroquinolones. J Antimicrob Chemother 2001; 47:655-8
97.
KH Chan, JSH Tam, JSM Peiris, WH Seto, MH Ng: Epstein-Barr virus (EBV) infection in infancy. J of Clin Virology 2001 (21):57-62
98.
Pak-Leung Ho, Wing-Cheong Yam, Terrence Kin-Man Cheung , Wilson Wai-Shing Ng , Tak-Lun Que, Dominic Ngai-Chong Tsang , Tak-Keung Ng ,
Wing-Hong Seto:
Fluoroquinolone resistance among Streptococcus pneumoniae in Hong Kong linked to the Spanish 23F clone. Emerging Infectious Diseases, 2001: Vol 7: No. 3: 906-908
99.
PL Ho,* RWH Yung, DNC Tsang, TL Que, M Ho, WH Seto, TK Ng, WC Yam, Wilson WS Ng:
Increasing resistance of Streptococcus pneumoniae to fluoroquinolones:results of a Hong Kong multi-centre study in 2000" (Accepted for J Antimicrob Chemother)
100. KH Chan, MH Ng, WH Seto, M Peiris: Epstein-Barr Virus (EBV) DNA in Sera of Patients with Primary EBV Infections J of Clinicial Microbiology 2001 vol 39 (11) 4152 - 4154
101.
Kumana C, Ching TY, Kong Y, Ma E, Kou M, Lee R, Cheng C, Chiu S Seto WH: Curtailing unnecessary vancomycin usage in a hospital with high rates of methicillin resistant Staphylococcus aureus infections. Br J Clin Pharmacol, 2001:52,427-432
102.
WH Seto: Spread of Antibiotic Resistance: Impact of Infection Control Measures. Nosocomial and Health Care Associated Infections in Urology, World Health Organization & International Union Against Cancer. 2001: 98-104.
103.
CR Kummana, WH Seto, WK Lam: Editorial: The Anthrax Letter. Internal Medicine Journal of Thailand 2002:18;1:3-5
104.
KH Chan, N Malddis, W Pope, A Yup, A Ozinskas, J Gill, WH Seto, KF Shortridge, and JSM Peiris: Evaluation of the Directigen FluA + B Test for Rapid Diagnosis of Influenza Virus Type A and B Infections. J of Clin Microbiol 2002 (40)5:1675-1680
105.
WH Seto, D Tsang, RM Yung et al: Effectiveness of droplets and contact precautions in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 2003:May:1519 –1520
106.
WH Seto, D Tsang: SARS infection control. Lancet: 2003:July:76-77.
107.
Tsang KW, Ho PL, Ooi GC, Yee WK, Wang T, Chan-Yeung M, Lam WK, Seto WH, Yam LY, Cheung TM, Wong PC, Lam B, Ip MS, Chan J, Yuen KY, Lai KN. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003 May 15;348(20):1977-85
108.
Kwok H Chan, Yao L Gu, Fai Ng, Park SP Ng, Wing H Seto, Jonathan ST Sham, Daniel Chua, William Wei, Yue L Chen, Winsie Luk, Yong S Zong and Mun H Ng: EBV Specific Antibody-Based and DNA-Based Assays in Serologic Diagnosis of Nasopharyngeal Carcinoma. Int J Cancer, 2003:105,706-709
109.
PL Ho, XP Tang, WH Seto: SARS: Hospital Infection Control and Admission Strategies. Respirology 2003:8:S41-45
110.
Lam MF, Ooi GC, Lam B, Ho JC, Seto WH, Ho PL, Wong PC, Liang R, Lam WK, Tsang KW: An Indolent Case of Severe Acute Respiratory Syndrome. Am J Respir Crit Care Med 2004:169:125-128
111.
K Tsang, WH Seto: Severe acute respiratory syndrome: Scientific and anecdotal evidence for drug treatment. Current Opinion in Investigational Drugs, 2004
5(2):179-185
112. K Chan, L Poon, V Cheng, Y Guan, I Hung, J Kong, L Yam, Y Yam, W Seto, K Yuen, J Peiris: Detection of SARS Coronavirus in Patients with Suspected SARS. EID 2004;10(2),294-299
112.
WC Yam, KH Chan, KH Chow, LLM Poon, HY Lam, KY Yuen, WH Seto, JSM Peiris: Clinical evaluation of real-time PCR assays for rapid diagnosis of SARS coronavirus during outbreak and post-epidemic periods. J Clin Virol 2005;33:19-24
113.
KH Chan, VCC Cheng, PCY Woo, SKP Lau, LLM Poon, Y Guan, WH Seto, KY Yuen, JSM Peirs: Serological Responses inpatients with Severe Acute Respiratory Syndrome Coronavirus Infection with Cross-reactivity with Human Coronaviruses 229E, Oc43, and NL63. Clin Diagnostic Lab Imm Nov. 2005: 1317-1321
Book:
With ML Ling & TY Ching
Infection Control for the Asian Healthcare Worker.
Excerpta Medica, Hong Kong, 1999
Infection Control for the Asian Healthcare Worker.
Excerpta Medica, 2nd Edition, Hong Kong, 2004
Also >80 abstracts in proceedings of International conferences, available on request.
|
发表于 2008-12-9 00:05
发表于 2008-12-10 09:15
发表于 2008-12-11 17:33
发表于 2008-12-20 09:56
发表于 2009-1-28 11:09